Steven Valiquette Analyst PerformanceSteven Valiquette Equity Research Analyst for Healthcare, Technology, & Real Estate Sectors at MizuhoSteven Valiquette is a stock analyst at Mizuho focused in the medical sector, covering 26 publicly traded companies. Over the past year, Steven Valiquette has issued 40 stock ratings, including buy, hold, and sell recommendations. While full access to Steven Valiquette's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Steven Valiquette's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings71 Last 10 YearsBuy Recommendations47.76% 32 Buy RatingsCompanies Covered26 Unique Companies Ratings Distribution67RatingsDistribution of strong buy, buy, hold, and sell ratings by Steven Valiquette.RatingPercentageCount Strong Buy0.0%0 ratings Buy47.8%32 ratings Hold46.3%31 ratings Sell6.0%4 ratingsOut of 67 total stock ratings issued by Steven Valiquette at Mizuho, the majority (47.8%) have been Buy recommendations, followed by 46.3% Hold and 6.0% Sell.Best & Worst CallsBest Call000.0%ALGNOct 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ALGNApr 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE69.2% of companies on NYSE18 companiesNASDAQ30.8% of companies on NASDAQ8 companiesSteven Valiquette, an analyst at Mizuho, currently covers 26 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical22 companies84.6%Services1 company3.8%Computer and Technology1 company3.8%Manufacturing1 company3.8%Finance1 company3.8%Steven Valiquette of Mizuho specializes in stock coverage within the Medical sector, with additional focus on Services and Computer and Technology companies.Coverage IndustriesIndustryPercentageMEDICAL SERVICES8 companies30.8%MED/DENTAL - SUPP5 companies19.2%MED - HMO3 companies11.5%MED - HOSPITALS3 companies11.5%MEDICAL INFO SYS2 companies7.7%SERVICES – COMPUTER PROGRAMMING AND DATA PROCESSING1 company3.8%MED PRODUCTS1 company3.8%INTERNET SOFTWARE1 company3.8%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES1 company3.8%REIT - EQTY TRUST - OTHER1 company3.8% Steven Valiquette's Ratings History at Mizuho Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsDOCSDoximity5/14/2026Lower Price Target$23.52$26.00Neutral$0.0000.00% ROIXRAYDENTSPLY SIRONA5/6/2026Lower Price Target$11.37$14.00Neutral$0.0000.00% ROIHSICHenry Schein5/6/2026Lower Price Target$74.46$82.00Neutral$0.0000.00% ROIPHRPhreesia3/24/2026Lower Price Target$11.17$19.00Outperform$0.0000.00% ROILFMDLifeMD3/16/2026Upgrade$3.98$8.00Outperform$0.0000.00% ROIXRAYDENTSPLY SIRONA3/2/2026Boost Price Target$14.68$16.00Neutral$0.0000.00% ROIGDRXGoodRx2/27/2026Lower Price Target$1.87$3.00Neutral$0.0000.00% ROIHSICHenry Schein2/25/2026Boost Price Target$81.85$88.00Neutral$0.0000.00% ROINVSTEnvista2/10/2026Boost Price Target$29.40$27.00Neutral$0.0000.00% ROIDOCSDoximity2/10/2026Lower Price Target$27.53$34.00Neutral$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. CAHCardinal Health2/6/2026Boost Price Target$227.78$235.00Outperform$0.0000.00% ROIMCKMcKesson2/5/2026Boost Price Target$819.58$885.00Neutral$0.0000.00% ROIALGNAlign Technology2/5/2026Boost Price Target$161.30$215.00Outperform$0.0000.00% ROIWAYWaystar2/4/2026Set Price Target$24.04$42.00$0.0000.00% ROIPHRPhreesia2/4/2026Set Price Target$12.75$22.00$0.0000.00% ROIHSICHenry Schein1/20/2026Set Price Target$79.98$81.00Neutral$0.0000.00% ROIXRAYDENTSPLY SIRONA1/20/2026Boost Price Target$12.21$14.00Neutral$0.0000.00% ROIALGNAlign Technology1/20/2026Boost Price Target$171.49$200.00Outperform$0.0000.00% ROINVSTEnvista1/20/2026Set Price Target$25.24$24.00Neutral$0.0000.00% ROISOLVSolventum1/20/2026Set Price Target$79.59$100.00Outperform$0.0000.00% ROINVSTEnvista1/20/2026Upgrade$24.33$24.00Hold$0.0000.00% ROISOLVSolventum1/20/2026Upgrade$78.87$100.00Outperform$0.0000.00% ROICAHCardinal Health1/12/2026Set Price Target$201.06$222.00$0.0000.00% ROIMDLNMedline1/12/2026Initiated Coverage$40.52$48.00Outperform$0.0000.00% ROIPHRPhreesia12/10/2025Lower Price Target$15.82$28.00Outperform$0.0000.00% ROILFMDLifeMD11/19/2025Lower Price Target$4.04$6.00Neutral$0.0000.00% ROIGDRXGoodRx11/6/2025Lower Price Target$3.33$4.00Neutral$0.0000.00% ROICORCencora11/6/2025Boost Price Target$352.83$380.00Outperform$0.0000.00% ROICAHCardinal Health11/3/2025Boost Price Target$190.22$210.00Outperform$0.0000.00% ROINVSTEnvista11/3/2025Set Price Target$20.33$19.00$0.0000.00% ROIWAYWaystar10/30/2025Boost Price Target$39.62$50.00Outperform$0.0000.00% ROICORCencora10/30/2025Boost Price Target$333.20$340.00Outperform$0.0000.00% ROICORCencora10/16/2025Boost Price Target$320.02$334.00Outperform$0.0000.00% ROIALGNAlign Technology10/13/2025Lower Price Target$125.79$170.00Outperform$0.0000.00% ROIMCKMcKesson9/24/2025Boost Price Target$761.14$770.00Neutral$0.0000.00% ROIVEEVVeeva Systems8/29/2025Boost Price Target$268.31$325.00Outperform$0.0000.00% ROIPHRPhreesia8/27/2025Initiated Coverage$30.85$36.00Outperform$0.0000.00% ROINVSTEnvista8/1/2025Boost Price Target$20.71$18.00Underperform$0.0000.00% ROITDOCTeladoc Health7/25/2025Initiated Coverage$8.20$10.00Neutral$0.0000.00% ROIWAYWaystar6/30/2025Initiated Coverage$39.76$48.00Outperform$0.0000.00% ROINobody Understands Why Trump Is Invading Iran (here’s the answer) (Ad)Most investors are reacting to the Iran strikes without understanding the underlying motive driving the decision. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there is a hidden reason behind the bombing - and knowing it could change how you position your money right now.Discover the real reason behind the Iran strikes before markets react Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageMorgan StanleyJefferies Financial GroupStifel NicolausOppenheimerBerenberg BankRoth MkmWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.The Goldman Sachs GroupTD Cowen Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
